Drug treatment modalities in psychiatric inpatient practice: A 20-year comparison

European Archives of Psychiatry and Clinical Neuroscience

Volumn 255, Issue 2, 2005, Pages 136-142

  Barbui, Corrado ^a   Ciuna, Arcangelo ^a   Nosè, Michela ^a   Levi, Deborah ^a   Andretta, Margherita ^b   Patten, Scott B ^c   Amaddeo, Francesco ^a   Tansella, Michele ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b ULSS 20   (Italy)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Drug treatment; Epidemiology; Inpatients; Polypharmacotherapy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MENTAL HEALTH SERVICE; MENTAL PATIENT; OBSERVATION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REGISTER; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DRUG UTILIZATION; FEMALE; HUMANS; INPATIENTS; ITALY; MALE; MENTAL DISORDERS; MIDDLE AGED; PRESCRIPTIONS, DRUG; PSYCHIATRY; PSYCHOTROPIC DRUGS; REGISTRIES; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS;

EID: 17644399794     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-004-0546-6     Document Type: Article

References (27)

1. Amaddeo F, Beecham J, Bonizzato P, Fenyo A, Tansella M, Knapp M (1997) The use of a case register to evaluate the costs of psychiatric care. Acta Psychiatr Scand 95:159-198
2. Andretta M, Ciuna A, Corbari L, Cipriani A, Barbui C (2004) Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy. Social Psychiatry Psychiatr Epidemiol (in press)
3. Baldessarini RJ, Kando JC, Centorrino F (1995) Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. Am J Psychiatry 152:1038-1044
4. Barbui C, Campomori A, D'Avanzo B, et al. (1999) Antidepressant drug use since the introduction of SSRI: national trends, regional differences, and impact on suicide rates. Soc Psychiatry Psychiatr Epidemiol 34:152-156
5. Barbui C, Campomori A, Mezzalira L (2001) Psychotropic drug use in Italy 1984-1999: the impact of a change in reimbursement status. Int Clin Psychopharmacol 16:227-233
6. Barbui C, Danese A, Guaiana G, Mapelli L, Miele L, Monzani E, Percudani M, on behalf of the Study group (2002) Prescribing second-generation antipsychotics and the evolving standard of care in Italy. Pharmacopsychiatry 6:239-243
7. Barbui C, Ciuna A, Nosé M, Patten SB, Stegagno M, Burti L, Amaddeo F, Tansella M (2004) Off-label and non-classical prescriptions of antipsychotic agents in ordinary inpatient practice. Acta Psychiatr Scand 109:275-278
8. Bowers L, Callaghan P, Clark N, Evers C (2004) Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe. Eur J Clin Pharmacol DOI: 10.1007/s00228-003-0719-7
9. Centorrino F, Eakin M, Bahk W-M, Kelleher JP, Goren J, Salvatore P, Egli S, Baldessarini R (2002) Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry 159:1932-1935
10. Ciuna A, Andretta M, Corbari L, Levi D, Mirandola M, Sorio A, Barbui C (2004) Are we going to increase the use of antidepressants up to that of benzodiazepines? Eur J Clin Pharmacol (in press)
11. Efron B, Tibshirani R (1986) Bootstrap methods of standard errors, confidence intervals, and other measures of statistical accuracy. Stat Science 1:54-77
12. Freudenreich O, Goff DC (2002) Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psych Scand 106:323-330
13. Isacsson G, Boethius G, Henriksson S, et al. (1999) Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord 53:15-22
14. Italian Collaborative Study Group on the Outcome of Severe Mental Disorders (1999) Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. Eur J Clin Pharmacol 55:685-690
15. Lavik NJ (1983) Utilization of mental health services over a given period. Acta Psychiatr Scand 67:404-413
16. Lawrenson RA, Tyrer F, Newson RB, et al. (2000) The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 59:149-157
17. Lernfelt B, Samuelsson O, Skoog I, Landahl S (2003) Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 59:637-644
18. McCue R, Waheed R, Urcuyo L (2003) Polypharmacy in patients with schizophrenia. J Clin Psychiatry 64:948-989
19. Miller AL, Craig CS (2002) Combination antipsychotics: pros, cons, and questions. Schizophrenia Bull 28:105-109
20. Mond J, Morice R, Owen C, Korten A (2003) Use of antipsychotic medications in Australia between July 1995 and December 2001. Austr N Z J Psychiatry 37:55-61
21. Nosé M, Barbui C, Tansella M (2003) How often do patients with psychosis fail to adhere with treatment programs? A systematic review. Psychol Med 33:1149-1158
22. Rothbard AB, Kuno E, Foley K (2003) Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia. Schizophrenia Bull 29:531-540
23. Santamaria B, Perez M, Montero D, Madurga M, de Abajo FJ (2002) Use of antipsychotic agents in Spain through 1985-2000. Eur Psychiatry 17:471-476
24. Tansella M, Amaddeo F, Burti L, Garzotto N, Ruggeri M (1998) Community-based mental health care in Verona, Italy. In: Goldberg D, Thornicroft G (eds) Mental Health in Our Future Cities. Psychology Press: Hove (UK), pp 239-262
25. Tansella M, Burti L (2003) Integrating evaluative research and community-based mental health care in Verona, Italy. Br J Psychiatry 183:167-169
26. Weiss E, Hummer M, Koller D, Ulmer H, Fleischhacker WW (2000) Off-label use of antipsychotic drugs. J Clin Psychopharmacol 20:695-698
27. WHO Collaborating Centre for Drug Statistic Methodology (2003) Guidelines for ATC Classification and DDD Assignment. WHO Collaborating Centre for Drug Statistic Methodology, Oslo, Norway